脇坂 理紗

Differences in PD-L1, PD-L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study. 

Head & neck 2025年3月28日  査読有り

A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study. 

Clinical and experimental nephrology 28(12) 1254-1260 2024年12月  査読有り

Prognostic Value of the 18F-FDG PET/CT and Haematological Parameters in Head and Neck Cancer. 

Clinical otolaryngology 49(6) 733-741 2024年11月  査読有り筆頭著者

Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD-L1 and PD-L2. 

Head & neck 46(9) 2233-2243 2024年9月  査読有り

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer. 

Cancers 16(17) 2024年8月29日  査読有り筆頭著者

Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer. 

Head & neck 46(8) 2056-2067 2024年8月  査読有り

Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. 

Cancer science 115(4) 1073-1084 2024年4月  査読有り

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers. 

Cancers 16(6) 2024年3月19日  査読有り

Efficacy of Cetuximab Combined with Paclitaxel in Patients with Recurrent Salivary Gland Carcinoma: A Retrospective Observational Study. 

ORL; journal for oto-rhino-laryngology and its related specialties 86(1) 41-49 2024年  査読有り

Common Characteristics of Sinonasal Inflammation Associated with IgG4-Related Disease and Other Chronic Inflammatory Diseases: A Retrospective Observational Study. 

ORL; journal for oto-rhino-laryngology and its related specialties 86(2) 95-100 2024年  査読有り

Harnessing Immunity to Treat Advanced Thyroid Cancer. 

Vaccines 12(1) 2023年12月30日  査読有り

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. 

Cancer immunology, immunotherapy : CII 72(8) 2799-2812 2023年8月  査読有り

Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases. 

Auris, nasus, larynx 50(4) 628-631 2023年8月  査読有り

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. 

Cancer immunology, immunotherapy : CII 72(7) 2087-2098 2023年7月  査読有り

Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation. 

Cancer science 114(2) 399-409 2023年2月  査読有り

The efficacy of PD-1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study. 

Laryngoscope investigative otolaryngology 7(6) 1808-1813 2022年12月  査読有り

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer. 

Translational oncology 18 101358-101358 2022年4月  査読有り

Antitumor Peptide-Based Vaccine in the Limelight. 

Vaccines 10(1) 2022年1月3日  査読有り

Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma. 

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 47(1) 228-233 2022年1月  査読有り

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. 

Oncoimmunology 11(1) 2021619-2021619 2022年  査読有り